Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Node-positive Breast Cancer: early-phase trial registry
3 of 5 indexed Node-positive Breast Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Node-positive Breast Cancer: 5 US clinical trials tracked, 3 recruiting.
Node-positive Breast Cancer is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University Hospital, Basel, Switzerland, running 1 of these trials.
Enrollment posture brief
Registry condition node-positive-breast-cancer
OPEN 3 | RECR 60% | LATE 0 | EARLY 2 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)
Node-positive Breast Cancer lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Node-positive Breast Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Node-positive Breast Cancer is recruiting above its size-band peers.
3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Node-positive Breast Cancer research.
University Hospital, Basel, Switzerland accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Node-positive Breast Cancer enrolment sits around 137 participants.
Median target enrolment is 137 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.
-
Node-positive Breast Cancer research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)
University Hospital, Basel, Switzerland
NCT03513614
Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer
Washington University School of Medicine
NCT06559540
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
NCT06833502
Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer
Virginia Commonwealth University
NCT02515110
Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation
Medical College of Wisconsin
NCT02348684
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Node-positive Breast Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Node-positive Breast Cancer trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Node-positive Breast Cancer page
5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Node-positive Breast Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University Hospital, Basel, Switzerland sponsors the most Node-positive Breast Cancer trials on record, review their full trial history before evaluating a specific study. See University Hospital, Basel, Switzerland's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Node-positive Breast Cancer condition card totals 5 registered trials; most-linked intervention Radiation therapy groups; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.